-=Amwell (AMWL) reported earnings on Wed 12 May 21 (a/h)

 

Amwell beats by $0.02, misses on revs; guides FY21 revs in-line 

Reports Q1 (Mar) loss of $0.16 per share, $0.02 better than the S&P Capital IQ Consensus of ($0.18); revenues rose 7.3% year/year to $57.6 mln vs the $58.78 mln S&P Capital IQ Consensus.

• Total active providers of approximately 81,000 at the end of the first quarter increased 240% compared to a year ago
• Total visits of 1.6 million in the first quarter increased 120% compared to a year ago. 

Co issues in-line guidance for FY21, sees FY21 revs of $260-270 mln vs. $266.73 mln S&P Capital IQ Consensus.

• AMG visit volume between 1.5 and 1.7 million
• Adjusted EBITDA between ($157) million and ($147) million